Back to search

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Data up to Jan 2025

Published2010
Citations2,531
References27

Total Citations Per Year

Abstract

References (27)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

Nonparametric Estimation from Incomplete Observations

1958 • 7,673 citations

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

2005 • 4,912 citations

Multiple sclerosis

2008 • 3,973 citations

Defining the clinical course of multiple sclerosis

1996 • 3,606 citations

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

2004 • 2,462 citations

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

2010 • 2,146 citations

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

2002 • 1,655 citations

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

2002 • 1,478 citations

Diagnostic criteria for multiple sclerosis

2001 • 1,337 citations

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

2006 • 1,043 citations

Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions

2009 • 639 citations

Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology

2007 • 524 citations

FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system

2009 • 429 citations

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

2009 • 371 citations

Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis

2007 • 316 citations

FTY720 modulates human oligodendrocyte progenitor process extension and survival

2007 • 251 citations

The pathogenesis of Friedreich ataxia and the structure and function of frataxin

2009 • 239 citations

Oral fingolimod (FTY720) in multiple sclerosis

2009 • 193 citations

The Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors

2007 • 173 citations

Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules

2009 • 159 citations

FTY720: Placebo‐Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects

2006 • 111 citations

Assessing disability progression with the Multiple Sclerosis Functional Composite

2009 • 99 citations

ELEMENTAL MERCURY NEUROTOXICITY FROM SELF-INJECTION

2009 • 6 citations

Teaching Neuro Image : Cerebral T-waves from an aneurysmal cardunculus compression

2008 • 4 citations

Fingolimod Enhances Myelin Basic Protein Expression and Modulates Cytokine Production Following an Interferon-gamma Mediated Insult in the Whole Brain Aggregate Cell Culture System

2009 • 3 citations

Cited By (0)

No citing papers found in database

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis (2010) – New England Journal of Medicine | Metascience Observatory Explorer